A recent paper found that in miR-200b-transfected breast cancer cells, the levels of IL-1β, IL-18, ASC, caspase 1, and NLRP3 were firstly increased by miR-200b, then enhanced by nobiletin [53]. This evidence concerns the gene IL18 and breast carcinoma.